Tilray Brands Inc vs Visa Inc — how do they compare? Tilray Brands Inc trades at $4.27 (market cap $524.07M), while Visa Inc trades at $356.84 (market cap $685.71B). The key difference: Visa Inc is far larger — about 1308.4× Tilray Brands Inc's market cap, and Visa Inc pays a 0.74% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.
| TLRY | V | |
|---|---|---|
Market Cap | $524.07M | $685.71B |
Sector | Health | Financials |
52-Week High | $21.00 | $365.14 |
52-Week Low | $4.23 | $295.52 |
Enterprise Value | $621.22M | $696.30B |
Volume | — | 10,431,336 |
Dividend Yield | — | 0.74% |
Signals from Pluang's Aura AI — not financial advice
TLRY trades at $4.23, down 1.63% with bearish technical signals. The company reported revenue growth to $821.31M in 2025 but faces severe profitability challenges with a net loss of $2.19B and negative margins. Recent expansion includes medical cannabis launches in Panama and strategic acquisitions, while analyst consensus shows cautious sentiment with 65% hold ratings.
The outlook remains challenging due to persistent losses and high debt levels, though expansion initiatives and potential regulatory changes offer long-term opportunities. Key risks include execution on profitability, competitive pressures, and cannabis regulatory uncertainty.
Visa (V) trades at $355.85, down 0.76% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $396.70 implying 11.5% upside. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $3.31 exceeding the $3.10 estimate, and maintains robust profitability with a net income margin over 51%. Recent news highlights Visa's focus on AI-driven commerce and stablecoin partnerships to enhance its payment network.
Visa's outlook remains positive due to consistent earnings growth, high margins, and strategic initiatives in AI and digital payments. Key risks include competitive pressures from fintech and regulatory scrutiny. With 85% of analysts rating it a Buy and institutional ownership increasing, the stock presents a compelling long-term opportunity, though investors should monitor execution on innovation and macroeconomic impacts on consumer spending.
Trailing returns across standard periods
Latest headlines on both assets
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →Visa Inc. operates a retail electronic payments network and manages global financial services. The Company also offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Read more on V →